Answers are grounded in this paper and cite their sources.
Sickle cell disease (SCD) is the most common inherited hemoglobinopathy affecting ~100,000 people in the United States alone.Patients with SCD suffer many complications, including acute vaso-occlusive crises (VOC) and pain crises.These episodes of pain crises are a major reason for emergency room visits and admissions for pain control.Given the current opioid epidemic, treating pain in sickle cell crises presents a great challenge.Pain control in SCD is still not well understood, and patients can have their pain inadequately treated, sometimes as a result of medical team bias.This article discusses the current state of pain management amongst patients with SCD and the novel approach implemented at The Ohio State University Wexner Medical Center with a multidisciplinary clinic.
No takes yet. Share an insight, caveat, or question.
Husain et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: